{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:28:12Z","timestamp":1750102092817,"version":"3.37.3"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"1100","license":[{"start":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T00:00:00Z","timestamp":1477440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["14\/040, 14\/1002"],"award-info":[{"award-number":["14\/040, 14\/1002"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["14\/040, 14\/1002"],"award-info":[{"award-number":["14\/040, 14\/1002"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,6,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Evidence from randomised controlled trials shows that low-molecular-weight heparin is effective in reducing the risk of venous thromboembolism (VTE) in the clinical setting of temporary lower limb immobilisation. Despite this, international guidelines are non-committal in advocating the use of anticoagulation in this clinical scenario. We determined the risk of VTE associated with lower limb immobilisation and the proportion of VTE events associated with lower limb immobilisation by undertaking a secondary analysis of two case\u2013control studies that had used a similar methodology.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We undertook logistic regression analysis to investigate the association of risk factors with VTE with the OR and 95% CIs for association between lower limb immobilisation and VTE the primary outcome variable. The proportion of VTE patients with lower limb immobilisation was also calculated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Cases comprised 396 patients aged 18\u201365\u2005years with radiologically confirmed deep vein thrombosis or pulmonary embolism attending outpatient VTE clinics. Controls, also aged 18\u201365\u2005years, comprised 197 inpatients in the coronary care unit and 200 outpatients treated for upper limb injuries in the fracture clinic. The OR for association between VTE and lower limb immobilisation was 73.1 (95% CI 10.1 to 530, p&amp;lt;0.001). In 62\/396 (16%) cases, patients had undergone lower limb immobilisation within four weeks of their presentation with VTE, representing the most common potentially preventable cause of VTE in this sample.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Lower limb immobilisation is associated with a markedly increased risk of VTE and represents the most common potentially preventable cause in the 18\u201365-year age group, being present in one in seven cases treated for VTE. Consideration should be given to pharmacological prophylaxis in patients with lower limb immobilisation to reduce the substantial burden of preventable VTE.<\/jats:p><\/jats:sec>","DOI":"10.1136\/postgradmedj-2016-134365","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T03:09:47Z","timestamp":1477537787000},"page":"354-359","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Lower limb immobilisation and venous thromboembolism risk: combined case\u2013control studies"],"prefix":"10.1093","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5327-3027","authenticated-orcid":false,"given":"Irene","family":"Braithwaite","sequence":"first","affiliation":[{"name":"Medical Research Institute of New Zealand , Wellington, New Zealand"},{"name":"Department of Medicine, Capital and Coast District Health Board , Wellington, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Healy","sequence":"additional","affiliation":[{"name":"Medical Research Institute of New Zealand , Wellington, New Zealand"},{"name":"Department of Medicine, Capital and Coast District Health Board , Wellington, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laird","family":"Cameron","sequence":"additional","affiliation":[{"name":"Medical Research Institute of New Zealand , Wellington, New Zealand"},{"name":"Department of Medicine, Capital and Coast District Health Board , Wellington, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Weatherall","sequence":"additional","affiliation":[{"name":"Rehabilitation Teaching and Research Unit, University of Otago Wellington , Wellington, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Beasley","sequence":"additional","affiliation":[{"name":"Medical Research Institute of New Zealand , Wellington, New Zealand"},{"name":"Department of Medicine, Capital and Coast District Health Board , Wellington, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,10,26]]},"reference":[{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ejvs.2002.1778","article-title":"Incidence of diagnosed deep vein thrombosis in the general population: systematic review","volume":"25","author":"Fowkes","year":"2003","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/archinte.162.11.1245","article-title":"Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study","volume":"162","author":"Heit","year":"2002","journal-title":"Arch Intern Med"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archinte.167.9.935","article-title":"Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom","volume":"167","author":"Huerta","year":"2007","journal-title":"Arch Intern Med"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(11)61904-1","article-title":"Pulmonary embolism and deep vein thrombosis","volume":"379","author":"Goldhaber","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"2023041308203441400_","first-page":"I4","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJM198610093151503","article-title":"A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery","volume":"315","author":"Turpie","year":"1986","journal-title":"N Engl J Med"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/bjs.1800800607","article-title":"Prophylaxis of postoperative thromboembolism with low molecular weight heparins","volume":"80","author":"J\u00f8rgensen","year":"1993","journal-title":"Br J Surg"},{"issue":"(4)","key":"2023041308203441400_","first-page":"CD005981","article-title":"Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement","author":"Salazar","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"issue":"(4)","key":"2023041308203441400_","first-page":"CD006681","article-title":"Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization","author":"Testroote","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1538-7836.2008.02984.x","article-title":"Prevention of venous thromboembolism in patients with immobilization of the lower extremities: a meta-analysis of randomized controlled trials","volume":"6","author":"Ettema","year":"2008","journal-title":"J Thromb Haemost"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00003086-199803000-00028","article-title":"Thromboembolism after foot and ankle surgery: a multicentre study","volume":"348","author":"Mizel","year":"1998","journal-title":"Clin Orthop Relat Res"},{"issue":"(4)","key":"2023041308203441400_","first-page":"CD006681","article-title":"Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization","author":"Testroote","year":"2008","journal-title":"Cochrane Database of Syst Rev"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1258\/jrsm.2010.100155","article-title":"Prolonged work- and computer-related seated immobility and risk of venous thromboembolism","volume":"103","author":"Healy","year":"2010","journal-title":"J R Soc Med"},{"key":"2023041308203441400_","first-page":"2054270416632670","article-title":"Venous thromboembolism risk associated with protracted work- and computer-related seated immobility: a case-control study","volume-title":"J R Soc Med Open","author":"Braithwaite","year":"2016"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1182\/asheducation-2011.1.150","article-title":"Is thrombophilia testing useful?","author":"Middledorp","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archinternmed.2007.5","article-title":"Minor injuries as a risk factor for venous thrombosis","volume":"168","author":"van Stralen","year":"2008","journal-title":"Arch Intern Med"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/s00167-009-0727-y","article-title":"High incidence of deep venous thrombosis after Achilles tendon rupture: a prospective study","volume":"17","author":"Nilsson-Helander","year":"2009","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11999-011-2166-6","article-title":"Incidence of deep vein thrombosis and pulmonary embolism after Achilles tendon rupture","volume":"470","author":"Patel","year":"2011","journal-title":"Clin Orthop Relat Res"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1302\/0301-620X.92B5.23241","article-title":"Venous thromboembolism following prolonged cast immobilisation for injury to the tendo Achillis","volume":"92","author":"Healy","year":"2010","journal-title":"J Bone Joint Surg Br"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial","volume":"355","author":"Pulmonary Embolism Prevention Collaborative Trial Group","year":"2000","journal-title":"Lancet"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/jth.13224","article-title":"Venous thromboembolism rates in patients with lower limb immobilisation after Achilles tendon injury are unchanged after the introduction of prophylactic aspirin: audit","volume":"14","author":"Braithwaite","year":"2016","journal-title":"J Thromb Haemost"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMoa0800374","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty","volume":"358","author":"Eriksson","year":"2008","journal-title":"N Engl J Med"},{"key":"2023041308203441400_","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1056\/NEJMoa076016","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty","volume":"358","author":"Lassen","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/93\/1100\/354\/49841185\/postgradmedj-93-354.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/93\/1100\/354\/49841185\/postgradmedj-93-354.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T16:53:46Z","timestamp":1692550426000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/93\/1100\/354\/6984407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,26]]},"references-count":24,"journal-issue":{"issue":"1100","published-online":{"date-parts":[[2016,10,26]]},"published-print":{"date-parts":[[2017,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2016-134365","relation":{},"ISSN":["1469-0756","0032-5473"],"issn-type":[{"type":"electronic","value":"1469-0756"},{"type":"print","value":"0032-5473"}],"subject":[],"published-other":{"date-parts":[[2017,6]]},"published":{"date-parts":[[2016,10,26]]}}}